CN111616364A - 一种红参阿胶饮品及其在保健饮品中的应用 - Google Patents
一种红参阿胶饮品及其在保健饮品中的应用 Download PDFInfo
- Publication number
- CN111616364A CN111616364A CN202010629187.7A CN202010629187A CN111616364A CN 111616364 A CN111616364 A CN 111616364A CN 202010629187 A CN202010629187 A CN 202010629187A CN 111616364 A CN111616364 A CN 111616364A
- Authority
- CN
- China
- Prior art keywords
- donkey
- hide gelatin
- red ginseng
- beverage
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010010803 Gelatin Proteins 0.000 title claims abstract description 62
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 62
- 229920000159 gelatin Polymers 0.000 title claims abstract description 62
- 239000008273 gelatin Substances 0.000 title claims abstract description 62
- 235000019322 gelatine Nutrition 0.000 title claims abstract description 62
- 235000011852 gelatine desserts Nutrition 0.000 title claims abstract description 62
- 235000013361 beverage Nutrition 0.000 title claims abstract description 51
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 59
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 20
- 230000036541 health Effects 0.000 claims abstract description 9
- 102000008186 Collagen Human genes 0.000 claims description 27
- 108010035532 Collagen Proteins 0.000 claims description 27
- 229920001436 collagen Polymers 0.000 claims description 27
- 241000251468 Actinopterygii Species 0.000 claims description 20
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 17
- 108010052008 colla corii asini Proteins 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 15
- 241000287828 Gallus gallus Species 0.000 claims description 14
- 229920001277 pectin Polymers 0.000 claims description 12
- 239000001814 pectin Substances 0.000 claims description 12
- 235000010987 pectin Nutrition 0.000 claims description 12
- 229920001285 xanthan gum Polymers 0.000 claims description 12
- 239000000230 xanthan gum Substances 0.000 claims description 12
- 235000010493 xanthan gum Nutrition 0.000 claims description 12
- 229940082509 xanthan gum Drugs 0.000 claims description 12
- 239000000084 colloidal system Substances 0.000 claims description 10
- 235000021560 apple concentrated juice Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 22
- 239000008213 purified water Substances 0.000 abstract description 21
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract description 15
- 230000036039 immunity Effects 0.000 abstract description 12
- 240000001008 Dimocarpus longan Species 0.000 abstract description 9
- 235000000235 Euphoria longan Nutrition 0.000 abstract description 9
- 241000168517 Haematococcus lacustris Species 0.000 abstract description 8
- 229920001202 Inulin Polymers 0.000 abstract description 8
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract description 8
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract description 8
- 229940029339 inulin Drugs 0.000 abstract description 8
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract description 7
- 230000007812 deficiency Effects 0.000 abstract description 7
- 230000000968 intestinal effect Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000002124 endocrine Effects 0.000 abstract description 5
- 206010034568 Peripheral coldness Diseases 0.000 abstract description 4
- 235000015197 apple juice Nutrition 0.000 abstract description 3
- 235000020418 red date juice Nutrition 0.000 abstract description 3
- 230000003860 sleep quality Effects 0.000 abstract description 3
- 208000000044 Amnesia Diseases 0.000 abstract description 2
- 208000026139 Memory disease Diseases 0.000 abstract description 2
- 230000003796 beauty Effects 0.000 abstract description 2
- 230000006984 memory degeneration Effects 0.000 abstract description 2
- 208000023060 memory loss Diseases 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 18
- 240000004371 Panax ginseng Species 0.000 description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 235000008434 ginseng Nutrition 0.000 description 12
- 239000004386 Erythritol Substances 0.000 description 10
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 10
- 235000019414 erythritol Nutrition 0.000 description 10
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 10
- 229940009714 erythritol Drugs 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000004376 Sucralose Substances 0.000 description 6
- 241001506047 Tremella Species 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 235000019408 sucralose Nutrition 0.000 description 6
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 5
- 235000005976 Citrus sinensis Nutrition 0.000 description 5
- 240000002319 Citrus sinensis Species 0.000 description 5
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 5
- 239000000212 ceratonia siliqua l. fruit extract Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000007865 diluting Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 3
- 229940107187 fructooligosaccharide Drugs 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 201000002364 leukopenia Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 235000002673 Dioscorea communis Nutrition 0.000 description 2
- 241000544230 Dioscorea communis Species 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000035753 Periorbital contusion Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 125000002124 5'-adenosyl group Chemical group N1=CN=C2N(C=NC2=C1N)[C@H]1[C@H](O)[C@H](O)[C@H](O1)C* 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000701408 Euphorbia kansui Species 0.000 description 1
- 241000434018 Euphorbia pekinensis Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000004693 neuron damage Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003307 reticuloendothelial effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种红参阿胶饮品及其在保健饮品中的应用，通过巧妙性将蛋白肽、红参、阿胶、菊粉、苹果浓缩汁、红枣浓缩汁、阿胶肽、雨生红球藻、γ‑氨基丁酸、桂圆粉等对人体友好、滋补的组分进行混合配以纯净水进行调和成饮品，不仅大大方便使用者进行饮用，同时，采用精细化的配方比例和各组分的协同效果配合，使得本方案的饮品具有一定程度的补气血、美容养颜、调节睡眠质量、调节内分泌、改善肠道菌群稳定和提高人体免疫力的效果，因此，其可以适用于八大人群，包括：1、熬夜族加班族；2、易感人群；3、记忆力下降人群；4、内分泌失调人群；5、面色暗黄人群；6、易疲劳人群；7、免疫力低下人群；8、气血不足手脚冰凉人群。
Description
技术领域
本发明涉及饮品技术领域，尤其是功能保健饮品领域，具体是涉及一种红参阿胶饮品及其在保健饮品中的应用。
背景技术
随着人们生活水平的日益提高，个人健康问题也越来越成为当前人们日常沟通的热门议题，其中，皮肤问题、精神状态问题、消化道问题和免疫力问题是当前人体健康问题较为关注的，对于一些工作强度大、过敏体质或体虚人群而言，一旦其身体发生不适，很容易便体现出来，例如，长期熬夜加班、娱乐引发的内分泌失调问题使得脸部痘痘常年无法消除，随之容易导致皮肤出现暗沉、缺乏水分和瘙痒等问题，另外，高强度工作下带来的记忆力下降、免疫力下降和血气不足问题也是长期困扰当今上班族的问题；然而目前大部分人对日常保健的印象大多停留在老年人才需要的观念上，而且市销的保健品中，大多也是针对中老年人或者是一些特殊症状人群，尤其是在保健、功能饮品上，目前还是相对较为少见有专门针对身体保健、调理的饮品。
发明内容
针对现有技术的情况，本发明的目的在于提供一种保健效果佳、饮用便利、能够改善人体免疫力和辅助增强生命动力的红参阿胶饮品及其在保健饮品中的应用。
为了实现上述的技术目的，本发明所采用的技术方案为：
一种红参阿胶饮品，其原料包括如下重量份的组分：
作为一种可能的实施方式，进一步，所述的红参为红参浸膏；且所述红参阿胶饮品中的红参浸膏的含量不低于300mg/100ml；所述的阿胶为阿胶粉。
作为一种可能的实施方式，进一步，所述的胶体由为果胶和黄原胶组成；所述黄原胶和果胶的添加比例为1～3∶1～4。
作为一种可能的实施方式，进一步，所述的蛋白肽由鸡肉蛋白肽、鱼胶原蛋白肽组成；所述鸡肉蛋白肽和鱼胶原蛋白肽的添加比例为1～2∶1～3。
作为一种较优的实施选择，优选的，所述红参阿胶饮品中的鱼胶原蛋白肽的含量不低于6000mg/100ml。
作为一种可能的实施方式，进一步，所述苹果浓缩汁和红枣浓缩汁的添加量之和在原料组分中的占比为≥10％。
作为一种可能的实施方式，进一步，所述红参阿胶饮品中的阿胶肽的含量不低于100mg/100ml。
作为一种较优的选择实施方式，优选的，本方案原料包括如下重量份的组分：
本方案中，各组分的简要介绍如下：
红参经过深加工后的红参浸膏，具有调节中枢神经系统、促进大脑对能量物质的利用、改善心脏功能、降血糖作用、增强机体的免疫功能、提高对有害刺激的抵御能力、抗肿瘤作用和抗氧化作用，另外红参浸膏还具有有补气、滋阴、益血、生津、强心、健胃、镇静等功效。在补虚方面一般认为红参浸膏强于普通人参浸膏，久服红参浸膏可以提高人体免疫力、抗疲劳、抗辐射、抑制肿瘤、调整人体内分泌系统；红参浸膏适合于老人、久病体虚者，另外，红参浸膏具有火大、劲足、功效强之特点，是阴盛阳虚者的首选补品，医药上治疗虚脱或强补多用红参浸膏。作为一种较优的选择，本方案采用韩国红参。
阿胶为马科动物驴的皮去毛后熬制而成的胶块，其药理功能主药为：滋阴补血、安胎、治血虚、虚劳咳嗽、吐血、衄血、便血、妇女月经不调、崩中和胎漏。其中，古代医药类典籍中均有记载阿胶的药理作用，例如：《神农本草经》中提及：阿胶主心腹内崩，劳极洒洒如疟状，腰腹痛，四肢酸疼，女子下血。安胎。久服益气。《别录》中提及：丈夫小腹痛，虚劳羸瘦，阴气不足，脚酸不能久立，养肝气。《药性论》中提及：主坚筋骨，益气止痢。《千金·食治》中提及：治大风。《孟诜》中提及：治一切风毒骨节痛，呻吟不止者，消和洒服。《日华子本草》中提及：治一切风，并鼻洪、吐血、肠风、血痢及崩中带下。《本草纲目》中提及：疗吐血、衄血、血淋、尿血，肠风，下痢。女人血痛、血枯、经水不调，无子，崩中，带下，胎前产后诸疾。男女一切风病，骨节疼痛，水气浮肿，虚劳咳嗽喘急，肺痿唾脓血，及痈疽肿毒。和血滋阴，除风润燥，化痰清肺，利小便，调大肠。《纲目拾遗》中提及：治内伤腰痛，强力伸筋，添精固肾。
菊粉是除淀粉外植物的另一种能量储存的形式是十分理想的功能性食品配料、同时也是生产低聚果糖、多聚果糖、高果糖浆、结晶果糖等产品的良好原料，其具有控制血糖、降低血糖、促进矿物质吸收、调节肠道微生物菌群，改善肠道健康和防止便秘的功效，还具有抑制有毒发酵产物的生成，保护肝脏，预防结肠癌的作用，另外，菊粉中有少量的2-9低聚果糖，研究表明，低聚果糖可使大脑神经细胞营养因子表达升高，对皮质酮诱导的神经元损作有很好的保护作用，具有良好的抗抑郁作用，同时，其还具有美肤、祛湿和辅助减肥排脂的效果。
苹果浓缩汁(Apple juice concentrate)具有辅助排毒、辅助减肥和助消化功效，苹果汁中含有大量的膳食纤维，其能够刺激肠胃蠕动，加快体内排泄，缩短有害物质在体内留置的时间，预防肠胃疾病和消化道癌症，另外，纤维素可以推迟血糖升高，有效防止糖尿病。
红枣浓缩汁是采用红枣进行破碎、深加工后，去除一定量水分和杂质制成的浓缩物，其富含丰富的红枣多糖，对于保持心脑血管的健康来说是非常重要的物质，而将新鲜红枣做成浓缩红枣汁更是提升了红枣的营养价值，在中药学里，浓缩红枣汁的功效可分为：1、健脾益胃，脾胃虚弱、腹泻、倦怠无力的人，每日吃红枣七颗，或与党参、白术共用，能补中益气、健脾胃，达到增加食欲、止泻的功效；红枣和生姜、半夏同用，可治疗饮食不慎所引起的胃炎如胃胀、呕吐等症状；2、补气养血：红枣为补养佳品，食疗药膳中常加入红枣补养身体、滋润气血；有学者提倡平时多吃红枣、黄耆、枸杞，能提升身体的元气，增强免疫力；养血安神：女性躁郁症、哭泣不安、心神不宁等，用红枣和甘草、小麦同用〈甘麦大枣汤〉，可起到养血安神、舒肝解郁的功效。在精神紧张、心中烦乱、睡眠不安或一般更年期症候群时，中医的处方常配加红枣，主要是红枣有镇静作用；4、红枣常被用于药性剧烈的药方中，以减少烈性药的副作用，并保护正气，现有中药处方中还常见使用大枣缓解甘遂、大戟、芜花等泻药的毒性，保护脾胃不受伤害；5、红枣成份中的维他命C含量较高，而且含有环磷酸腺甘及山楂酸等成份，经过研究证实以上三者均含有抑制癌症的效果，也就是说红枣有好的预防癌症功效，适合现代环境的健康食品。
赤藓糖醇是一种4碳糖醇，可由葡萄糖发酵制得，其具有：1、低热量：赤藓糖醇的热量低，其能量值为1.65kJ/g，而蔗糖为16.7kJ/g，木糖醇为11.7kJ/g，赤藓糖醇是能量最低的功能糖，热量仅有蔗糖热量的十分之一。2、耐受性高：人体对赤藓糖醇的耐受量为每千克体重为0.8克，比木糖醇、乳糖醇和麦芽糖醇都高，主要原因是赤藓糖醇的分子量小，吸收少，主要通过尿液排出，从而避免了高渗现象造成腹泻发生，避免了肠道细菌发酵产生胀气现象；3、抗龋齿性：赤藓糖醇不被人体口腔细菌利用，因而不会产生酸性物质对牙齿造成伤害，从而引生牙齿发生龋变，对口腔细菌生长产生抑制效果，从而起到保护牙齿的作用。
桂圆富含糖分和多种维生素，具补心益脾、养血安神等功效，由其打磨出的桂圆粉不仅有益成分更易吸收。
血橙果粉中富含维生素c，可以帮助人体提高免疫力的同时提亮肤色、淡化色斑。
银耳多糖为担子菌多糖类免疫增强剂，有改善机体免疫功能及提升白细胞的作用。实验研究表明，银耳多糖能显著提高小鼠网状内皮细胞的吞噬功能，对环磷酰胺所致的大鼠白细胞减少有预防和治疗作用。临床用于肿瘤化疗或放疗所致的白细胞减少症和其他原因所致的白细胞减少症，有显著效果。
雨生红球藻是一种主要生长在淡水中的单细胞绿藻，在海洋中分布很少，但海水中的盐度有利于藻体中虾青素的累积。雨生红球藻是公认的在自然界中生产天然虾青素的最理想来源，虾青素作为目前发现的一种最高效的纯天然抗氧化剂，在清除自由基、抗衰老、抗肿瘤和免疫调节等方面显示出良好的生物活性，被广泛应用于功能性食品、医药以及化妆品领域，另外，雨生红球藻的清除自由基能力是维生素C的6000倍，维E的1000倍。
三氯蔗糖的甜味纯正，甜感呈现速度快且其甜味持续时间及后味等方面均非常接近蔗糖，但是，由于其在人体内不参与代谢，不被人体吸收，热量值为零，因此是当前较为理想的甜味代用品。
水苏糖对人体胃肠道内的双歧杆菌、乳酸杆菌等有益菌群有着极明显的增殖作用，能迅速改善人体消化道内环境，调节微生态菌群平衡。它能促进形成有益菌在消化道内的优势菌地位，抑制产气产酸梭状芽孢杆菌等腐败菌的生产，另外产生大量生理活性物质，调节肠道pH值、灭杀致病菌，阻遏腐败产物生成，抑制内源致癌物的产生和吸收，并且分解衍生出多重免疫功能因子。
鱼胶原蛋白肽是一种高分子功能性蛋白质，而胶原蛋白是皮肤的主要组成部分，占皮肤真皮层80％的比重。它在皮肤中构成了一张细密的弹力网，牢固锁住水分支撑着皮肤。鱼胶原蛋白肽具有的功效繁多，包括：1、抗皱延衰：胶原蛋白胎具有修复断裂老化的弹力纤维网重整肌肤组织结构舒展皱纹；另外还清除体内自由基、抗氧化减缓皮肤衰老；2、抚平细纹、消除红血丝：胶原蛋白肽进入真皮层后能迅速填补塌陷组织收紧皮肤增强弹性平复细纹预防和消除红血丝；3、淡斑祛斑：胶原蛋白能使细胞连接更紧密加快新陈代谢速度促进死皮脱落防止黑色素沉积令肤色白皙淡斑；4、美白靓肤：胶原蛋白能抑制黑色素的产生防止黑色素沉积从而达到美白的目的；5、修复黑眼圈、眼袋：促进眼周围皮肤微循环加强眼部肌肤新陈代谢使其滋润、保水改善眼袋及黑眼圈；6、健美乳房：胶原蛋白是结缔组织的主要成分与弹性蛋白及多糖蛋白相互交织成网状结构产生一定的机械强度承托起下垂的乳房使乳房挺拔、丰满、富有弹性。
鸡肉蛋白肽为鸡肉中提取的蛋白肽成分，其具有促进细胞生长、抗紫外线照射及皮肤晒后修复、抗衰及清除自由基、消炎祛痘、深度补水、容易吸收等美容护肤效果。
γ-氨基丁酸是中枢神经系统中重要的神经传导物质，主要存在于脑和脊髓中，并在人体大脑皮质、海马、丘脑、基底神经节和小脑中起重要作用，并对机体的多种功能具有调节作用。人体约有50％的中枢突触是以GABA为递质的，其具有助眠安神、提高睡眠质量的作用，还具有抗焦虑和能有效的改善脑血流通，增加氧的供给，促进脑的代谢功能的作用。
角豆提取物富含蛋白质、维生素、微量元素，可以为人体补充营养物质，提高能量。
作为本方案红参阿胶饮品的拓展应用或应用涵盖，其可以为：
一种红参阿胶保健饮品，其包括上述所述的红参阿胶饮品。
一种饮品，其包括上述所述的红参阿胶饮品。
采用上述的技术方案，本发明与现有技术相比，其具有的有益效果为：本方案巧妙性将红参、阿胶、菊粉、苹果浓缩汁、红枣浓缩汁、阿胶肽、鱼胶原蛋白肽、雨生红球藻、γ-氨基丁酸、桂圆粉等对人体友好、滋补的组分进行混合配以纯净水进行调和成饮品，不仅大大方便使用者进行饮用，同时，采用精细化的配方比例和各组分的协同效果配合，使得本方案的饮品具有一定程度的补气血、美容养颜、调节睡眠质量、调节内分泌、改善肠道菌群稳定和提高人体免疫力的效果，因此，其可以适用于八大人群，包括：1、熬夜族加班族；2、易感人群；3、记忆力下降人群；4、内分泌失调人群；5、面色暗黄人群；6、易疲劳人群；7、免疫力低下人群；8、气血不足手脚冰凉人群。
具体实施方式
实施例1
一种红参阿胶饮品，其原料包括如下重量份的组分：
其中，所述的红参为红参浸膏；所述的阿胶为阿胶粉。
另外，所述的胶体由为果胶和黄原胶组成；所述黄原胶和果胶的添加比例为1∶1。
所述的蛋白肽由鸡肉蛋白肽、鱼胶原蛋白肽组成；所述鸡肉蛋白肽和鱼胶原蛋白肽的添加比例为1∶2；
所述苹果浓缩汁和红枣浓缩汁的添加量之和在原料组分中的占比为≥10％。
本方案配方的简要调和方法包括如下步骤：
(1)取70份纯净水加入到调配罐中，然后将红参、阿胶、菊粉、苹果浓缩汁、红枣浓缩汁、赤藓糖醇、酵母β-葡聚糖、N-乙酰神经氨酸、桂圆粉、血橙果粉、银耳多糖、雨生红球藻、γ-氨基丁酸、柠檬酸、阿胶肽、蛋白肽、胶体、水苏糖、三氯蔗糖和角豆提取物加入到纯净水中进行混合调配，期间若是组分加入时出现混合体系干燥或部分结块现象，则加入纯净水进行稀释，直至干燥、结块现象接触，最终将剩余纯净水全部加入至混合体系中进行以50～60转/min的搅拌速度和40～60℃的温度进行混合处理4h；
(2)搅拌混合处理结束后，对调配罐内的混合体系进行过滤去除絮团或大颗粒沉淀，然后将混合体系输出，制得红参阿胶饮品；
(3)将所述的红参阿胶饮品存储于阴凉干燥且无阳光直射处。
产品检测
取制得的红参阿胶饮品进行组分含量检测，所得结果为：鱼胶原蛋白肽的含量为6021mg/100ml；阿胶肽的含量为116mg/100ml；红参浸膏的含量为314mg/100ml。
实施例2
一种红参阿胶饮品，其原料包括如下重量份的组分：
其中，所述的红参为红参浸膏；所述的阿胶为阿胶粉。
另外，所述的胶体由为果胶和黄原胶组成；所述黄原胶和果胶的添加比例为2∶1。
所述的蛋白肽由鸡肉蛋白肽、鱼胶原蛋白肽组成；所述鸡肉蛋白肽和鱼胶原蛋白肽的添加比例为1∶3；
所述苹果浓缩汁和红枣浓缩汁的添加量之和在原料组分中的占比为≥10％。
本方案配方的简要调和方法包括如下步骤：
(1)取70份纯净水加入到调配罐中，然后将红参、阿胶、菊粉、苹果浓缩汁、红枣浓缩汁、赤藓糖醇、酵母β-葡聚糖、N-乙酰神经氨酸、桂圆粉、血橙果粉、银耳多糖、雨生红球藻、γ-氨基丁酸、柠檬酸、阿胶肽、蛋白肽、胶体、水苏糖、三氯蔗糖和角豆提取物加入到纯净水中进行混合调配，期间若是组分加入时出现混合体系干燥或部分结块现象，则加入纯净水进行稀释，直至干燥、结块现象接触，最终将剩余纯净水全部加入至混合体系中进行以50～60转/min的搅拌速度和40～60℃的温度进行混合处理6h；
(2)搅拌混合处理结束后，对调配罐内的混合体系进行过滤去除絮团或大颗粒沉淀，然后将混合体系输出，制得红参阿胶饮品；
(3)将所述的红参阿胶饮品存储于阴凉干燥且无阳光直射处。
产品检测
取制得的红参阿胶饮品进行组分含量检测，所得结果为：鱼胶原蛋白肽的含量为6011mg/100ml；阿胶肽的含量为126mg/100ml；红参浸膏的含量为304mg/100ml。
实施例3
一种红参阿胶饮品，其原料包括如下重量份的组分：
其中，所述的红参为红参浸膏；所述的阿胶为阿胶粉。
另外，所述的胶体由为果胶和黄原胶组成；所述黄原胶和果胶的添加比例为2∶1。
所述的蛋白肽由鸡肉蛋白肽、鱼胶原蛋白肽组成；所述鸡肉蛋白肽和鱼胶原蛋白肽的添加比例为2∶3；
所述苹果浓缩汁和红枣浓缩汁的添加量之和在原料组分中的占比为≥10％。
本方案配方的简要调和方法包括如下步骤：
(1)取70份纯净水加入到调配罐中，然后将红参、阿胶、菊粉、苹果浓缩汁、红枣浓缩汁、赤藓糖醇、酵母β-葡聚糖、N-乙酰神经氨酸、桂圆粉、血橙果粉、银耳多糖、雨生红球藻、γ-氨基丁酸、柠檬酸、阿胶肽、蛋白肽、胶体、水苏糖、三氯蔗糖和角豆提取物加入到纯净水中进行混合调配，期间若是组分加入时出现混合体系干燥或部分结块现象，则加入纯净水进行稀释，直至干燥、结块现象接触，最终将剩余纯净水全部加入至混合体系中进行以50～60转/min的搅拌速度和40～60℃的温度进行混合处理2h；
(2)搅拌混合处理结束后，对调配罐内的混合体系进行过滤去除絮团或大颗粒沉淀，然后将混合体系输出，制得红参阿胶饮品；
(3)将所述的红参阿胶饮品存储于阴凉干燥且无阳光直射处。
产品检测
取制得的红参阿胶饮品进行组分含量检测，所得结果为：鱼胶原蛋白肽的含量为6045mg/100ml；阿胶肽的含量为121mg/100ml；红参浸膏的含量为304mg/100ml。
实施例4
一种红参阿胶饮品，其原料包括如下重量份的组分：
其中，所述的红参为红参浸膏；所述的阿胶为阿胶粉。
另外，所述的胶体由为果胶和黄原胶组成；所述黄原胶和果胶的添加比例为1∶4。
所述的蛋白肽由鸡肉蛋白肽、鱼胶原蛋白肽组成；所述鸡肉蛋白肽和鱼胶原蛋白肽的添加比例为1∶3；
所述苹果浓缩汁和红枣浓缩汁的添加量之和在原料组分中的占比为≥10％。
本方案配方的简要调和方法包括如下步骤：
(1)取70份纯净水加入到调配罐中，然后将红参、阿胶、菊粉、苹果浓缩汁、红枣浓缩汁、赤藓糖醇、酵母β-葡聚糖、N-乙酰神经氨酸、桂圆粉、血橙果粉、银耳多糖、雨生红球藻、γ-氨基丁酸、柠檬酸、阿胶肽、蛋白肽、胶体、水苏糖、三氯蔗糖和角豆提取物加入到纯净水中进行混合调配，期间若是组分加入时出现混合体系干燥或部分结块现象，则加入纯净水进行稀释，直至干燥、结块现象接触，最终将剩余纯净水全部加入至混合体系中进行以50～60转/min的搅拌速度和40～60℃的温度进行混合处理2h；
(2)搅拌混合处理结束后，对调配罐内的混合体系进行过滤去除絮团或大颗粒沉淀，然后将混合体系输出，制得红参阿胶饮品；
(3)将所述的红参阿胶饮品存储于阴凉干燥且无阳光直射处。
产品检测
取制得的红参阿胶饮品进行组分含量检测，所得结果为：鱼胶原蛋白肽的含量为6063mg/100ml；阿胶肽的含量为101mg/100ml；红参浸膏的含量为307mg/100ml。
以上所述为本发明实施例，对于本领域的普通技术人员而言，根据本发明的教导，在不脱离本发明的原理和精神的情况下凡依本发明申请专利范围所做的均等变化、修改、替换和变型，皆应属本发明的涵盖范围。
Claims (10)
1.一种红参阿胶饮品，其特征在于：其原料包括如下重量份的组分：
2.根据权利要求1所述的一种红参阿胶饮品，其特征在于：所述的红参为红参浸膏；且所述红参阿胶饮品中的红参浸膏的含量不低于300mg/100ml；所述的阿胶为阿胶粉。
3.根据权利要求1所述的一种红参阿胶饮品，其特征在于：所述的胶体由为果胶和黄原胶组成；所述黄原胶和果胶的添加比例为1～3∶1～4。
4.根据权利要求1所述的一种红参阿胶饮品，其特征在于：所述的蛋白肽由鸡肉蛋白肽、鱼胶原蛋白肽组成；所述鸡肉蛋白肽和鱼胶原蛋白肽的添加比例为1～2∶1～3。
5.根据权利要求4所述的一种红参阿胶饮品，其特征在于：所述红参阿胶饮品中的鱼胶原蛋白肽的含量不低于6000mg/100ml。
6.根据权利要求1所述的一种红参阿胶饮品，其特征在于：所述苹果浓缩汁和红枣浓缩汁的添加量之和在原料组分中的占比为≥10％。
7.根据权利要求1所述的一种红参阿胶饮品，其特征在于：所述红参阿胶饮品中的阿胶肽的含量不低于100mg/100ml。
8.根据权利要求1所述的一种红参阿胶饮品，其特征在于：其原料包括如下重量份的组分：
9.一种红参阿胶保健饮品，其特征在于：其包括权利要求1至8之一所述的红参阿胶饮品。
10.一种饮品，其特征在于：其包括权利要求1至8之一所述的红参阿胶饮品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010629187.7A CN111616364A (zh) | 2020-07-03 | 2020-07-03 | 一种红参阿胶饮品及其在保健饮品中的应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010629187.7A CN111616364A (zh) | 2020-07-03 | 2020-07-03 | 一种红参阿胶饮品及其在保健饮品中的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111616364A true CN111616364A (zh) | 2020-09-04 |
Family
ID=72267715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010629187.7A Pending CN111616364A (zh) | 2020-07-03 | 2020-07-03 | 一种红参阿胶饮品及其在保健饮品中的应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111616364A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112021482A (zh) * | 2020-09-30 | 2020-12-04 | 广州市爱百伊生物技术有限公司 | 角豆血橙饮及其制备方法 |
| CN112602861A (zh) * | 2020-12-10 | 2021-04-06 | 北京添易生物科技有限公司 | 一种用于提高免疫力的担子菌复合饮品及其制备方法 |
| CN112998269A (zh) * | 2021-03-19 | 2021-06-22 | 广州能靓生物技术有限公司 | 一种口服美容组合物及其应用 |
| CN113855587A (zh) * | 2021-09-06 | 2021-12-31 | 武汉中科光谷绿色生物技术有限公司 | 一种抑制美拉德反应的组合物及其应用 |
| CN113966795A (zh) * | 2021-10-22 | 2022-01-25 | 深圳荣耀植物智能科学有限公司 | 一种人参饮品及其制作方法 |
| CN114886116A (zh) * | 2022-03-18 | 2022-08-12 | 广东丸美生物技术股份有限公司 | 一种调理育龄女性健康的组合物及其制备方法和饮料及应用 |
| CN117224614A (zh) * | 2023-10-30 | 2023-12-15 | 广东时代食品与生命健康研究有限公司 | 一种具有益气养血作用的复合发酵物及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106942538A (zh) * | 2017-03-28 | 2017-07-14 | 山东华胶饮品有限公司 | 阿胶人参果汁复合饮料的配方及其制备方法 |
| CN110420313A (zh) * | 2019-08-11 | 2019-11-08 | 梁裕宽 | 一种阿胶人参饮品的生产工艺及其方法 |
| CN110537648A (zh) * | 2019-10-13 | 2019-12-06 | 无锡嬿侣生物科技有限公司 | 一种燕窝胶原蛋白肽饮品 |
-
2020
- 2020-07-03 CN CN202010629187.7A patent/CN111616364A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106942538A (zh) * | 2017-03-28 | 2017-07-14 | 山东华胶饮品有限公司 | 阿胶人参果汁复合饮料的配方及其制备方法 |
| CN110420313A (zh) * | 2019-08-11 | 2019-11-08 | 梁裕宽 | 一种阿胶人参饮品的生产工艺及其方法 |
| CN110537648A (zh) * | 2019-10-13 | 2019-12-06 | 无锡嬿侣生物科技有限公司 | 一种燕窝胶原蛋白肽饮品 |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112021482A (zh) * | 2020-09-30 | 2020-12-04 | 广州市爱百伊生物技术有限公司 | 角豆血橙饮及其制备方法 |
| CN112021482B (zh) * | 2020-09-30 | 2022-11-08 | 广州市爱百伊生物技术有限公司 | 角豆血橙饮及其制备方法 |
| CN112602861A (zh) * | 2020-12-10 | 2021-04-06 | 北京添易生物科技有限公司 | 一种用于提高免疫力的担子菌复合饮品及其制备方法 |
| CN112998269A (zh) * | 2021-03-19 | 2021-06-22 | 广州能靓生物技术有限公司 | 一种口服美容组合物及其应用 |
| CN112998269B (zh) * | 2021-03-19 | 2022-09-02 | 广州能靓生物技术有限公司 | 一种口服美容组合物及其应用 |
| CN113855587A (zh) * | 2021-09-06 | 2021-12-31 | 武汉中科光谷绿色生物技术有限公司 | 一种抑制美拉德反应的组合物及其应用 |
| CN113855587B (zh) * | 2021-09-06 | 2023-11-24 | 武汉中科光谷绿色生物技术有限公司 | 一种抑制美拉德反应的组合物及其应用 |
| CN113966795A (zh) * | 2021-10-22 | 2022-01-25 | 深圳荣耀植物智能科学有限公司 | 一种人参饮品及其制作方法 |
| CN114886116A (zh) * | 2022-03-18 | 2022-08-12 | 广东丸美生物技术股份有限公司 | 一种调理育龄女性健康的组合物及其制备方法和饮料及应用 |
| CN114886116B (zh) * | 2022-03-18 | 2023-11-21 | 广东丸美生物技术股份有限公司 | 一种调理育龄女性健康的组合物及其制备方法和饮料及应用 |
| CN117224614A (zh) * | 2023-10-30 | 2023-12-15 | 广东时代食品与生命健康研究有限公司 | 一种具有益气养血作用的复合发酵物及其制备方法和应用 |
| CN117224614B (zh) * | 2023-10-30 | 2024-04-30 | 广东时代食品与生命健康研究有限公司 | 一种具有益气养血作用的复合发酵物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111616364A (zh) | 一种红参阿胶饮品及其在保健饮品中的应用 | |
| CN102224891B (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
| CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
| CN114938835A (zh) | 一种二氢槲皮素sod胶原三肽饮配方 | |
| CN112602861A (zh) | 一种用于提高免疫力的担子菌复合饮品及其制备方法 | |
| CN103461585B (zh) | 补气养生中药茶 | |
| CN111374312A (zh) | 一种补充全面营养且易吸收的健康食品 | |
| CN113826908A (zh) | 一种具有增强体质和抗衰老功效的功能产品及其制备方法 | |
| CN113855766A (zh) | 一种可调理血压的银杏蛹虫草冲剂 | |
| CN103704568B (zh) | 临床膳食食品 | |
| CN105249440A (zh) | 一种阿胶糕 | |
| CN107668569A (zh) | 一种延缓衰老的海参蜂王浆及其生产方法 | |
| CN101991110B (zh) | 野生灵芝系列食品 | |
| CN111248324A (zh) | 一种用于阳虚体质的养生茶及其制备方法 | |
| CN109730222A (zh) | 酵素复合液及其保健饮料 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
| CN1142785C (zh) | 抗疲劳胶囊 | |
| CN101744945B (zh) | 胃肠功能调节口服液 | |
| CN104587425A (zh) | 一种驱寒膏的中药组成及制备方法 | |
| CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
| CN106035686A (zh) | 超级藜麦养生植物奶 | |
| CN105831735A (zh) | 藜麦婴幼儿超级营养粉 | |
| CN101352238A (zh) | 一种用于养颜美容的颗粒饮料及制作方法 | |
| CN110100985A (zh) | 保健品饮料 | |
| CN105994859A (zh) | 藜麦养颜咖啡 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200904 |